7 insiders reported 10 Form 4 transactions for DNA X, Inc. (SONM) over the past 18 months (most recent 2026-02-10). Recent activity: Crolius Clayton (Chief Financial Officer) Buy 35,000 shares, MULICA MICHAEL C (Acting CEO) Buy 50,000 shares, LYTTON LAURENCE W (10% Owner) Sell 466,402 shares, LYTTON LAURENCE W (10% Owner) Sell 400,514 shares, Cassano James S (Director) Sell 23,381 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-10 | Crolius Clayton | Chief Financial Officer | Buy | 35,000 | $0 |
| 2026-02-10 | MULICA MICHAEL C | Acting CEO | Buy | 50,000 | $0 |
| 2025-06-30 | LYTTON LAURENCE W | 10% Owner | Sell | 466,402 | $699,603 |
| 2025-06-30 | LYTTON LAURENCE W | 10% Owner | Sell | 400,514 | $556,714 |
| 2025-04-25 | Cassano James S | Director | Sell | 23,381 | $33,902 |
| 2025-04-25 | MULICA MICHAEL C | Director | Sell | 27,818 | $40,336 |
| 2025-04-25 | Wang Jeffrey | Director | Sell | 4,478 | $6,493 |
| 2025-04-25 | Steenstra Jack | Director | Sell | 23,381 | $33,902 |
| 2025-04-25 | Becher Charles | Chief Commercial Officer and General Manager of North America | Sell | 31,326 | $45,423 |
| 2025-04-25 | Crolius Clayton | Chief Financial Officer | Sell | 11,634 | $16,869 |
Source: SEC Form 4 filings · as of 2026-02-10